The Food and Drug Administration's Office of Drug Evaluation denied an appeal by PTC Therapeutics Inc. (Nasdaq: PTCT) of the regulatory agency's refuse to file letter. The stock price plummeted $5.30 to close at $7.97.
FDA denies PTC Therapeutics appeal
October 17, 2016 at 17:05 PM EDT